Viewing Study NCT05961761

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:00 PM
Ignite Modification Date: 2026-03-01 @ 9:54 PM
Study NCT ID: NCT05961761
Status: RECRUITING
Last Update Posted: 2023-07-27
First Post: 2023-06-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Sponsor: Niels Junker
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Soft Tissue Sarcoma Adult View
None Angiosarcoma View
None Undifferentiated Pleomorphic Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Propranolol View
None Pembrolizumab View
None PD-1 inhibitor View
None Sarcoma View